Gabriel Alarcon, DO
Family Medicine · Surprise, AZNPI 1336194695
Payments from drug & device makers
Across 49 payments — averaging $17.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$121
- GSK$112
- AbbVie$85
- Boehringer Ingelheim$66
- Boston Scientific$65
- Otsuka America Pharmaceutical, Inc.$63
- plus $343 from 12 others
What the payments were for
- Food & beverage$855100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 7 | $121 |
| GSK | 5 | $112 |
| AbbVie(2 entities) | 5 | $85 |
| Boehringer Ingelheim | 4 | $66 |
| Boston Scientific | 4 | $65 |
| Otsuka America Pharmaceutical, Inc. | 4 | $63 |
| Johnson & Johnson | 3 | $49 |
| Merck | 3 | $44 |
| Arbor Pharmaceuticals, Inc. | 2 | $43 |
| Pfizer | 3 | $43 |
| Lilly USA, LLC | 2 | $30 |
| Novo Nordisk | 1 | $22 |
| Daiichi Sankyo Inc. | 1 | $22 |
| Kowa Pharmaceuticals America, Inc. | 1 | $20 |
| Sunovion Pharmaceuticals Inc. | 1 | $19 |
| Teva Pharmaceuticals USA, Inc. | 1 | $19 |
| Amgen | 1 | $16 |
| Optinose US, Inc. | 1 | $16 |
How this compares
$855 in reported general payments places this provider in the 65th percentile of 2,099 family medicine providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 49 | $57,405 |
| JardianceEmpagliflozin | 25 | $34,013 |
| OzempicSemaglutide | 24 | $30,766 |
| MounjaroTirzepatide | 28 | $30,659 |
| XareltoRivaroxaban | 12 | $18,070 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 16 | $12,690 |
| MyrbetriqMirabegron | 12 | $12,585 |
| Breo ElliptaFluticasone/Vilanterol | 11 | $10,282 |
| Tresiba Flextouch U-100Insulin Degludec | 15 | $7,207 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 19 | $3,468 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 58 | $2,297 |
| Atorvastatin Calcium | 262 | $2,219 |
| Rosuvastatin Calcium | 116 | $1,948 |
| Pantoprazole Sodium | 77 | $1,617 |
| Metoprolol Succinate | 92 | $1,500 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $43 | $57,40549 claims |
| Boehringer IngelheimJardiance | $66 | $34,01325 claims |
| Novo NordiskOzempic | $22 | $30,76624 claims |
| Lilly USA, LLCMounjaro | $30 | $30,65928 claims |
| Johnson & JohnsonXarelto | $49 | $18,07012 claims |
| GSKBreo Ellipta | $112 | $10,28211 claims |
| Teva Pharmaceuticals USA, Inc.Proair Respiclick | $19 | $1,13815 claims |
| AbbVieSynthroid | $85 | $49319 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 2,099 family medicine providers in Arizona.
Other family medicine in Surprise
- Danielle ArmasScottsdale$73M
- Terry O'ReillyMesa$35.8M
- Shawn SearleChandler$27M
- Corey AndersonMesa$21.5M
- Dena PetersenTucson$14.7M
- Gerald ShockeyMesa$12.3M
- Brock MerrittPhoenix$8.4M
- John McGettiganTucson$8.3M
- Neil ShethChandler$6.7M
- Joseph LilloScottsdale$6.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.